|Table of Contents|

Clinical observation of postoperative prescription in the prevention of recurrence and metastasis of positive HER2 breast cancer

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2017 06
Page:
908-911
Research Field:
Publishing date:

Info

Title:
Clinical observation of postoperative prescription in the prevention of recurrence and metastasis of positive HER2 breast cancer
Author(s):
Geng Fengyong1; Zheng Yinghui2; Wang Yonghui2; Li Hui2; He Jinping2
1.General Hospital of China Aviation of China Medical University，Beijing 100012,China;2.General Hospital of North China Petroleum Administration Bureau，Hebei Renqiu 062550,China.
Keywords:
postoperative prescription; positive HER2 breast cancer; recurrence and metastasis; clinical efficacy
PACS:
R737.9
DOI:
10.3969/j.issn.1672-4992.2017.06.018
Abstract:
Objective:To study the clinical efficacy of postoperative prescriptionin the prevention of recurrence and metastasis of positive HER2 breast cancer（Chinese medicinal formulae）.Methods:All 90 patients with positive HER2 breast cancer were selected.The subjects were divided into study group and control group according to different therapies.The control group adopted the conventional western medicine.On the basis,the study group orally took the postoperative prescription.After 1 year of follow-up visit,the lymphatic metastasis was observed.Through the TCM syndrome,the clinical efficacy of postoperative prescription in the prevention of recurrence and metastasis of positive HER2 breast cancer was evaluated.Results:The rate of lymphatic metastasis was not significantly different (P＞0.05).Before surgery and after 3months of surgery,the evaluation score of TCM syndrome was not significantly different (P＞0.05).After 6 months,9 months and 12 months of surgery,the evaluation score of TCM syndrome for study group was significantly lower than control group (P＜0.05).The symptom score of fatigue,soreness and weakness of waist and knee,pain and number of contralateral breast lump was not significantly different (P＞0.05).After treatment,the symptom score for study group was significantly lower than control group (P＜0.05).Conclusion:The postoperative prescription can improve the clinical symptoms of fatigue,soreness and weakness of waist and knee,has a better effect in the contralateral breast hyperplasia and prevents the recurrence for positive HER2 breast cancer.

References:

［1］ Desmet CJ,Gallenne T,Prieur A,et al.Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis［J］.Proc Nat Acad Sci USA,2013,110(13):5139-5144.
［2］ Eryn B Callihan,Dexiang Gao,Sonali Jindal,et al.Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer［J］.Breast Cancer Res Treatment,2013,138(2):549-559.
［3］ Yu JI,Park W,Shin KH,et al.Prophylactic supraclavicular radiotherapy after surgery in high-risk N1 breast cancer［J］.Oncology,2013,85(1):14-20.
［4］ Harris EE,Freilich J,Lin HY,et al.The impact of the size of nodal metastases on recurrence risk in breast cancer patients with 1~3 positive axillary nodes after mastectomy［J］.Int J Radiation Oncol,Biol,Phys,2013,85(3):609-614.
［5］ Satoko Nishimura,Mitsuru Koizumi,Junko Kawakami,et al.Contralateral axillary node metastasis from recurrence after conservative breast cancer surgery［J］.Clin Nuclear Medicine,2014,39(2):181-183.
［6］ Gnant M,Filipits M,Greil R,et al.Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk:Using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone［J］.Ann Oncology,2014,25(2):339-345.
［7］ Roberts MR,Hong CC,Edge SB,et al.Case-only analyses of the associations between polymorphisms in the metastasis-modifying genes BRMS1 and SIPA1 and breast tumor characteristics,lymph node metastasis,and survival［J］.Breast Cancer Research,2013,139(3):873-885.
［8］ Wang J,Xie X,Wang X,et al.Locoregional and distant recurrences after breast conserving therapy in patients with triple-negative breast cancer:A meta-analysis［J］.Surgical Oncol,2013,22(4):247-255.
［9］ Glechner AW.Sentinel lymph node dissection only versus complete axillary lymph node dissection in early invasive breast cancer:A systematic review and meta-analysis［J］.Eur J Cancer,2013,49(4):812-825.
［10］ Ying Zhong,Songjie Shen,Yidong Zhou,et al.ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD242 phenotype［J］.Med Oncol,2014,31(3):864.
［11］ Kim HA,Lee JK,Kim EK,et al.Serum human epidermal growth factor receptor 2 levels as a real-time marker for tumor burden in breast cancer patients［J］.J Surg Oncol,2014,109(5):421-425.
［12］ Kim ST,Jeong H,Woo OH,et al.Tumor-infiltrating lymphocytes,tumor characteristics,and recurrence in patients with early breast cancer［J］.Am J Clin Oncol,2013,36(3):224-231.
［13］ Kapoor NS,Shamonki J,Sim MS,et al.Impact of multifocality and lymph node metastasis on the prognosis and management of microinvasive breast cancer［J］.Ann Surgical Oncology,2013,20(8):2576-2581.

Memo

Memo:
-
Last Update: 2017-01-26